Sujets d’actualité

FYidoctors is pleased to announce their significant purchase of CIRRUS™ HD-OCTs from Carl Zeiss Canada. This current technology system offers tools to aid in the management of glaucoma, retinal disease and anterior segment imaging for corneal disease.  CIRRUS HD-OCT will revolutionize early detection of common eye conditions and help FYidoctors manage disease, vastly improving coverage in our clinics from Coast to Coast. With over 160 years of innovation and as the creator of the OCT technology, ZEISS has over 10,000 OCTs in the market. ZEISS strives to serve doctors with complete solutions to support better workflows.   “For many years we have been a trusted…

More patients now have access to the excellent optics in ZEISS eyeglasses, as Carl Zeiss Vision Canada has just announced a distribution agreement with FYidoctors; one of Canada’s largest and fastest growing independent eye care companies in Canada. “ZEISS is a global leader in precision optics and diagnostic instrumentation, and will be a strong partner for FYidoctors,” said Alan Ulsifer, OD and CEO of FYidoctors. “We have been working with the i.Terminal 2 and OCT products with ZEISS for some time with great satisfaction.” He also added, “This new ZEISS certification agreement further demonstrates the FYidoctors’ commitment to produce high…